The global Office-Based Surgical Product market size was valued at USD 1.81 billion in 2024 and is expected to reach USD 3.36 billion by 2032, at a CAGR of 8.00% during the forecast period
The market growth is largely fueled by the increasing shift from hospital-based procedures to office-based surgeries, supported by advancements in minimally invasive technologies and enhanced surgical instrumentation. These trends are making office-based surgical settings more viable and cost-effective, leading to broader adoption across dermatology, gynecology, ophthalmology, ENT, and other specialties
Furthermore, rising patient preference for outpatient care, shorter recovery times, and reduced healthcare costs are establishing office-based surgical products as essential components in modern ambulatory care. These converging factors are accelerating the uptake of Office-Based Surgical Product solutions, thereby significantly boosting the industry's growth